Tang Carolyn C.
General Counsel
Tang Carolyn C. has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jun 12, 2026.
On the most recent filing, Tang Carolyn C. is listed as General Counsel at Arcus Biosciences, Inc. Inside the rolling window, Tang Carolyn C. reported no open-market purchases and 2 open-market sales totaling $318K in RCUS. The largest disclosed transaction in the window is a sale of 7,658 RCUS shares on Dec 16, 2025, worth $168K.
Companies traded
Other insiders at RCUS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$318K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Tang Carolyn C. made?
Tang Carolyn C. has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Tang Carolyn C. trade?
Tang Carolyn C. has filed SEC Form 4 disclosures for 1 company, including RCUS.
When was Tang Carolyn C.'s most recent SEC Form 4 filing?
Tang Carolyn C.'s most recent SEC Form 4 filing on Tracefour is dated Jun 12, 2026.
What is Tang Carolyn C.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Tang Carolyn C. is listed as General Counsel.
What is Tang Carolyn C.'s total buy and sell value in the current window?
Inside the rolling retention window, Tang Carolyn C. bought $0 and sold $318K based on SEC Form 4 filings.
What was Tang Carolyn C.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 7,658 RCUS shares on 2025-12-16, worth $168K, per SEC Form 4 filings.